NEW YORK (Reuters Health) May 21 - Rupatadine is significantly better than placebo for the treatment of chronic idiopathic urticaria, Spanish researchers report in the May issue of Allergy.

• 纽约路透社健康栏目5月21日报道，研究者发布在过敏症5月刊上的研究表明，卢帕他定治疗慢性特发性荨麻疹显著优于安慰剂。